Literature DB >> 20944708

Cancer-gene testing ramps up.

Ewen Callaway.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20944708     DOI: 10.1038/467766a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  4 in total

Review 1.  Clinical application of high-throughput genomic technologies for treatment selection in breast cancer.

Authors:  Aaron R Hansen; Philippe L Bedard
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466

2.  BLUEPRINT to decode the epigenetic signature written in blood.

Authors:  David Adams; Lucia Altucci; Stylianos E Antonarakis; Juan Ballesteros; Stephan Beck; Adrian Bird; Christoph Bock; Bernhard Boehm; Elias Campo; Andrea Caricasole; Fredrik Dahl; Emmanouil T Dermitzakis; Tariq Enver; Manel Esteller; Xavier Estivill; Anne Ferguson-Smith; Jude Fitzgibbon; Paul Flicek; Claudia Giehl; Thomas Graf; Frank Grosveld; Roderic Guigo; Ivo Gut; Kristian Helin; Jonas Jarvius; Ralf Küppers; Hans Lehrach; Thomas Lengauer; Åke Lernmark; David Leslie; Markus Loeffler; Elizabeth Macintyre; Antonello Mai; Joost H A Martens; Saverio Minucci; Willem H Ouwehand; Pier Giuseppe Pelicci; Hèléne Pendeville; Bo Porse; Vardhman Rakyan; Wolf Reik; Martin Schrappe; Dirk Schübeler; Martin Seifert; Reiner Siebert; David Simmons; Nicole Soranzo; Salvatore Spicuglia; Michael Stratton; Hendrik G Stunnenberg; Amos Tanay; David Torrents; Alfonso Valencia; Edo Vellenga; Martin Vingron; Jörn Walter; Spike Willcocks
Journal:  Nat Biotechnol       Date:  2012-03-07       Impact factor: 54.908

Review 3.  Personalized medicine in Europe: not yet personal enough?

Authors:  Antonello Di Paolo; François Sarkozy; Bettina Ryll; Uwe Siebert
Journal:  BMC Health Serv Res       Date:  2017-04-19       Impact factor: 2.655

Review 4.  Getting personalized cancer genome analysis into the clinic: the challenges in bioinformatics.

Authors:  Alfonso Valencia; Manuel Hidalgo
Journal:  Genome Med       Date:  2012-07-30       Impact factor: 11.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.